IL6 and central nervous system cancer: Consistent with this, studies have demonstrated that tumour progression in glioma is driven by an increase in proliferation and migration, and MSCs increase proliferation and maintain stemness in glioma via the IL‐6/gp130/STAT3 pathway.17, 18